FDA Allows Marketing of First Direct-to-Consumer App for Contraceptive Use to Prevent Pregnancy

FDAThe U.S. Food and Drug Administration permitted marketing of the first mobile medical application (app) that can be used as a method of contraception to prevent pregnancy. The app, called Natural Cycles, contains an algorithm that calculates the days of the month a woman is likely to be fertile based on daily body temperature readings and menstrual cycle information, a method of contraception called fertility awareness. Designed for mobile devices, it is intended for use in pre-menopausal women aged 18 and older.

Natural Cycles requires women to take their temperature daily using a basal body thermometer, in the morning immediately upon waking, and to enter the reading into the app, which also tracks a user’s menstrual cycle. Basal body thermometers are more sensitive than regular thermometers and detect a minor rise in temperature, only about half of one degree Fahrenheit, around the time of ovulation. Women using the app for contraception should abstain from sex or use protection (such as a condom) when they see "use protection" displayed on the app, which means they're more likely to be fertile during those days.

"Consumers are increasingly using digital health technologies to inform their everyday health decisions, and this new app can provide an effective method of contraception if it's used carefully and correctly," said Terri Cornelison, M.D., Ph.D., assistant director for the health of women in the FDA's Center for Devices and Radiological Health. "But women should know that no form of contraception works perfectly, so an unplanned pregnancy could still result from correct usage of this device."

Clinical studies to evaluate the effectiveness of Natural Cycles for use in contraception involved 15,570 women who used the app for an average of eight months. The app had a "perfect use" failure rate of 1.8 percent, which means 1.8 in 100 women who use the app for one year will become pregnant because they had sexual intercourse on a day when the app predicted they would not be fertile or because their contraceptive method failed when they had intercourse on a fertile day. The app had a "typical use" failure rate of 6.5 percent, which accounted for women sometimes not using the app correctly by, for example, having unprotected intercourse on fertile days.

Natural Cycles should not be used by women who have a medical condition where pregnancy would be associated with a significant risk to the mother or the fetus or those currently using birth control or hormonal treatments that inhibit ovulation. Natural Cycles does not provide protection against sexually transmitted infections.

The FDA reviewed the Natural Cycles app through the de novo premarket review pathway, a regulatory pathway for novel, low-to-moderate-risk devices of a new type. Along with this authorization, the FDA is establishing criteria, called special controls, which clarify the agency’s expectations in assuring the accuracy, reliability and effectiveness in preventing pregnancy using apps indicated for contraception. These special controls, when met along with general controls, provide a reasonable assurance of safety and effectiveness for apps used for contraception. This action also creates a new regulatory classification, which means that subsequent devices with the same intended use may go through the FDA's 510(k) process, whereby devices can obtain marketing authorization by demonstrating substantial equivalence to a predicate device.

Last year, the FDA released a Digital Health Innovation Action Plan to look at ways to provide clarity and find efficiency in how the agency regulates digital health technologies like the Natural Cycles app.

The FDA granted the marketing authorization for this app to Natural Cycles Nordic AB.

The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

Most Popular Now

Bayer Accelerates Six New Startups

Changing the experience of health: that's the focus of the six startups which the Bayer G4A team has included in the Accelerator program this year. The young companies from Canada...

Cerner Teams-Up with North London Partne…

Cerner has announced a new collaboration with North London Partners (NLP) - a partnership of health and care organisations across five London boroughs - to connect care information, share records...

Artificial Intelligence could Help Tackl…

Scientist from King’s College London believe that Artificial Intelligence could hold the key to identifying the best way to treat the country’s biggest killer, coronary heart disease (CHD). And now...

Researchers Use AI to Successfully Treat…

A translational research team led by the National University of Singapore (NUS) has harnessed CURATE.AI, a powerful artificial intelligence (AI) platform, to successfully treat a patient with advanced cancer, completely...

Greater Manchester Health and Social Car…

Greater Manchester Health and Social Care Partnership(GMHSC Partnership) aims to deliver rapid savings and identify how the cloud can support the region’s devolved vision for integratedhealth and careservices through work...

Philips Launches New Cardiac Ultrasound …

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today introduced the EPIQ CVx cardiovascular ultrasound system. Built on the powerful EPIQ ultrasound platform, EPIQ CVx is...

Orion Health Secures Place on Framework …

Orion Health has secured a place on a framework contract that will give health and care organisations easier access to the technology they need to deliver the NHS reform agenda...

Nottingham University Hospitals Switches…

Nottingham University Hospitals NHS Trust has completed a complex project to switch integration engines; on time, on budget, and with no disruption to services. The trust has a well-advanced 'best...

An Avatar Uses Your Gait to Predict How …

Humans instinctively adopt the gait that requires the least amount of energy given the walking conditions. Without realizing it, we are constantly tweaking our pace, stride length and foot lift...

Study on Cross-Border Health Services: E…

The overall objective of this study was to propose recommendations for improving the current level of information provision to patients by National Contact Points (NCPs). The research methodology used in...

Social Media in the Pharmaceutical Indus…

21 - 23 January 2019, London, UK. SMi Group are delighted to present the return of their 11th annual Social Media in the Pharmaceutical Industry conference to London on the 21st...

Kids Connect with Robot Reading Partners

Kids learn better with a friend. They're more enthusiastic and understand more if they dig into a subject with a companion. But what if that companion is artificial? Researchers at...